GlaxoSmithKline and Genmab refocus development programme for ofatumumab in autoimmune indications GlaxoSmithKline, 16 Sep 2010 Accessed on 15 Dec 2011 from http://www.gsk.com/media/pressreleases/2010/2010_pressrelease_10098.htm. CommentRecommendBookmarkWatch